Alexander Fisher

Prof. Alexander Fisher

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Journal of Orthopaedic Trauma
Verified
Journal Article
Closed access
AFAlexander Fisher
Alexander Fisher
MDM. W. Mbbs Davis
M. W. Mbbs Davis
SRS. E. MSocSc Rubenach
S. E. MSocSc Rubenach
SSS. Mbbs Sivakumaran
S. Mbbs Sivakumaran
PSP. N. Mbbs Smith
P. N. Mbbs Smith
MBM. M. B MedSc Budge
M. M. B MedSc Budge
Objectives To assess the impact of a specifically designed model of orthopedic-geriatric cocare on hip fracture (HF) outcomes. Setting Tertiary teaching hospital (level I trauma center). Design Prospective observational study with a retrospective (historical) control. Data on 951 consecutive patients 60 years of age or older admitted to the authors' institution with a nonpathologic HF over a 7-year period (1995 to 2002) were analyzed. Between 1995 and 1997, medical problems were managed by a geriatric medicine (GM) consultation-only service (retrospective audit). In 1998, a GM registrar began overseeing daily medical care with weekly geriatrician consultant review (prospective study). Outcomes for 2 time periods were compared: a 3-year period before (no GM; 504 patients) and a 4-year period after (GM; 447 patients) the introduction of GM cocare. Main Outcome Measurements Postoperative medical complications, mortality, length of stay, discharge destination, use of thromboprophylaxis, and antiosteoporotic treatment. Results While comparing 2 periods (GM and no GM), significant reductions in postoperative medical complications and comorbid conditions (in total 49.5% vs. 71.0%, P<0.001) and mortality (4.7% vs. 7.7%, P<0.01) occurred and rehospitalization to medical wards within 6 months decreased (28% vs. 7.6%). However, no differences were observed in median length of hospital stay (10.8 vs. 11.0 days) or in discharge destination. Antiosteoporotic treatment (12% to 69%) and specific thromboprophylaxis (63% to 94%) increased in the GM period. Conclusions Orthopedic-geriatric cocare for the older patients with HF was associated with significant reductions in morbidity and mortality, and increases in optimal postoperative care. Options for further improvement of orthopedic-GM cocare need to be investigated.

1 August 2009 in Bone
Verified
Journal Article
Closed access
AFAlexander Fisher
Alexander Fisher
EOE.D. O'Brien
E.D. O'Brien
MDM.W. Davis
M.W. Davis

1 July 2017 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
AFAlexander Fisher
Alexander Fisher
WSWichat Srikusalanukul
Wichat Srikusalanukul
LFLeon Fisher
Leon Fisher
PSPaul Smith
Paul Smith
Purpose: To estimate the discriminative value of serum P1NP/βCTX ratio and albumin levels in hospitalized orthogeriatric patients with and without nonvertebral fractures. Methods: In 1,239 orthogeriatric patients (mean age 78.1±9.52 years, 69.1% women) including 854 (68.9%) with osteoporotic nonvertebral fractures (455 [36.7%] with hip fracture [HF]) and 385 (31.1%) without fractures, markers of bone formation (procollagen type 1 N-terminal propeptide [P1NP], osteocalcin [OC], and bone resorption (beta-C-terminal cross-linking telopeptide of type 1 collagen [βCTX]), indices of mineral metabolism, and parameters of liver and renal functions were assessed; data on clinical and laboratory characteristics were collected prospectively. Results: Both lower serum P1NP/βCTX ratio and albumin concentration (as continuous or categorical variables) were independently associated with fracture presence in multivariate logistic regressions. Compared with the highest P1NP/βCTX tertile, the prevalence of HF, after adjustment for multiple covariates, was 3-fold higher in the lowest tertile and 1.5 times higher in the middle tertile; presence of any fracture was 2.3- and 1.6-fold higher, respectively; patients with albumin levels in the lowest tertile had multivariate odds ratio (OR) of 4.6 for HF and 2.8 for any fracture, in the middle tertile the ORs were 2.2 and 1.3, respectively. The P1NP/βCTX <100.0 (median) and hypoalbuminemia (<33 g/L) demonstrated area under the curve values for HF of 0.802 and 0.806, respectively, and for any fractures of 0.711 and 0.706, respectively. When both characteristics were combined, the ORs for HF or any fracture, compared with the nonfractured group, were 7.8 and 3.2, respectively, with an accuracy of 79.6% and 71.6%, respectively. Conclusions: In orthogeriatric patients, both serum P1NP/βCTX ratio and albumin levels demonstrated an inverse dose–effect relationship with the prevalence of nonvertebral fractures and independently indicated fracture presence with acceptable discriminatory power. Lower P1NP/βCTX (<100) and hypoalbuminemia could be useful simple additive prognostic tools for fracture risk stratification in the elderly.

15 January 2008 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
AFAlexander Fisher
Alexander Fisher
MDMichael W Davis
Michael W Davis
Objective: TO describe a case of QT interval prolongation, syncope, and delirium associated with galantamine use and to analyze similar cases related to acetylcholinesterase inhibitors (AChls) reported to the Australian Adverse Drug Reaction Advisory Committee (ADRAC). Case Summary: An 85–year-old man with dementia was treated with prolonged release galantamine 8 mg daily for 1.5 years. Three months prior to the current admission, he had a syncopal episode with low blood pressure and bradycardia. Two months later, galantamine was withdrawn, but within 2 weeks, the man developed marked cognitive, behavioral, and functional deterioration and galantamine was restarted. Three weeks later, he developed syncope, delirium, hypotension, and prolonged QT interval with serious cardiac arrhythmias, in addition to vomiting and diarrhea. A complete blood cell count and biochemistry panel performed on admission were normal. No infection was detected. Galantamine and irbesartan were ceased. The delirium fully resolved in 6 days, and the QT interval shortened from 503 to 443 msec (corrected by Bazett's formula) 4 days after discontinuation of galantamine and remained normal. Discussion: In the ADRAC reports, galantamine was associated with 18 cases of delirium/confusion. 8 of syncope, 13 of bradycardia, 6 of other arrhythmias or conducton abnormalities, and 6 of hypotension. Donepezil was associated with 56, 15, 26, 15, and 5, and rivastigmine with 21, 8, 6, 2, and 2, respectively, of these reactions. Five fatal outcomes were reported in association with galantamine, 11 with donepezil, and 3 with rivastigmine, including 3, 6, and 0 sudden deaths, respectively. This case, along with previously published reports and cases identified from the ADRAC database, illustrates that AChls may lead to delirium, syncope, hypotension, and life-threatening arrhythmias. The Naranjo probability scale indicated that galantamine was the probable cause of QT interval prolongation, syncope, and delirium in this patient. Conclusions: Administration of galantamine and other AChls requires vigilance and assessment of risk (actors that may precipitate QT interval prolongation, syncope, and delirium.

1 August 2010 in Bone
Verified
Journal Article
Closed access
AFAlexander Fisher
Alexander Fisher
WSWichat Srikusalanukul
Wichat Srikusalanukul
MDMichael Davis
Michael Davis
PSPaul Smith
Paul Smith

1 April 2018 in Injury
Verified
Journal Article
Closed access
AFAlexander Fisher
Alexander Fisher
LFLeon Fisher
Leon Fisher
WSWichat Srikusalanukul
Wichat Srikusalanukul
PSPaul N. Smith
Paul N. Smith